Champignon Brands Inc (CSE:SHRM) (OTCQB:SHRMF), a psychedelics company, announced Friday that it has filed acquisition reports related to its previous acquisitions of Artisan Growers Ltd, Novo Formulations Ltd and Tassili Life Sciences Corp.
The filings are part of Champignon’s commitment to cooperate with the British Columbia Securities Commission and complete its disclosure review in a timely fashion, the company said.
The review is regarding the company’s obligations since it became a reporting issuer in February.
READ: Champignon Brands says board decides against rebranding and changing company’s name
Champignon also announced that CEO Roger McIntyre has joined the company’s board of directors, replacing Pat McCutcheon, who will remain with the company in advisory capacity and assist with ongoing and planned capital market initiatives, according to the company.
Champignon specializes in the formulation of a suite of medicinal mushrooms health products as well as novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutritional, wellness and alternative medicine industries.
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel
